As at the date of this report, ResApp has received the one-time upfront payment of $3.0 million and an additional $0.25 million related
to the first milestone of $1.0 million. In addition, an invoice has been sent for the remaining $0.75 million
having now satisfied the full required clinical trial recruitment milestone. As a result, under the low,
preferred and high valuations, we have assumed ResApp receives both milestone payments in full.
0.25m received for data confirmation analysis
0.75m will be received as US trail recruitment finished
Evidence that Algo sensitivity improvement has either nearly been completed or a sure thing that won't affect the trail result?
If IE already has this information in the report, how can we wipe off value of other anns with negative data confirmation?
We will get to know about that after voting no.
NO - Vote Afterlife, page-17
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #